Biochemical markers and methods to assess insulin resistance in normal, obese and hyperandrogenic women;Marcadores bioquímicos y métodos de cuantificación de insulinorresistencia en mujeres normales, obesas e hiperandrogénicas

Revista Medica de Chile

Volumn 125, Issue 9, 1997, Pages 977-985

  Sir P, Teresa ^a,c   López S, Gloria ^a   Castillo A, Teresita ^b   Muñoz S, Silvana ^a   Durruty A, Pilar ^b   Calvillán C, Marcelo ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b Tecnólogo Médico ^*

^c HOSPITAL SAN JUAN DE DIOS   (Chile)

Author keywords

Dehydroepiandrosterone; Insulin resistance; Insulin like growth factors; Sex hormone binding globulin

Indexed keywords

BIOLOGICAL MARKER; INSULIN; PRASTERONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; OBESITY;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DEHYDROEPIANDROSTERONE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; OBESITY; SEX HORMONE-BINDING GLOBULIN; SOMATOMEDINS;

EID: 0031219593     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. WILLIAMS B. Insulin resistance: the shape of things to come. Lancet 1994; 344: 521-4.
2. DONAHUE RP. The insulin resistance syndrome (Syndrome X) and risk factors for coronary heart disease: An epidemiologic overview. The Endocrinologist 1994; 4: 112-6.
3. DUNAIF A. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent Diabetes Mellitus. Am J Med 1995; 98: 1A 33S-39S.
4. BARBIERI RL. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress. J Reprod Med 1994; 39: 327-36.
5. KIRSCHNER MA, SAMOJLIK E. Sex hormone metabolism in upper and lower body obesity. Intern J Obesity 1991; 15: 101-8.
6. PUGEAT M, CUAVE JC, ELMIDANI M, ET AL. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biocbem Biol 1991; 40: 841-9.
7. SUIKKARI AM, KOIVISTO VA, KOISTINEN R, ET AL. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988; 66: 166-72.
8. NESTLER JE, USISKIN KS, DASLASCINI CO, ET AL. Suppression of serum dehydroepiandrosterone sulfa levels by insulin: An evaluation of possible mechanism. J Clin Endocrinol Metab 1989; 69: 1040-6.
9. DE FRONZO RA, TOBIN JD, ANDRES R. Glucose clamp tecnique: A method for quantifying insulin action and resistance. Am J Physiol 1979; 232: E214-25.
10. CALVILLAN M, DURRUTY P, LOPEZ G, ROCHA G. Sensibilidad insulínica in vivo: Evaluación en pacientes diabéticos no insulinodependientes y en sujetos sanos por clamp euglicémico hiperinsulinémico. Rev Méd Chile 1991; 119: 1101-8.
11. WELCH S, GEBHART SP, BERGMAN RN, ET AL. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990; 71: 1508-18.
12. HIMSWORETH HP. Diabetes mellitus. Its differentiation into insulin sensitive and insulin insensitive types. Lancet 1936; i: 127-30.
13. BONORA E, MOGHETTI P, ZANCANARO C, ET AL. Estimates of in vivo insulin in man: comparison of insulin tolerance test with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-8.
14. SIR T, CASTILLO T, MUÑOZ S, CANDIA M, LOPEZ G, CALVILLAN M. Prueba de tolerancia a la insulina. Un método útil para determinar resistencia insulínica en mujeres hiperandrogénicas obesas. Rev Méd Chile 1996; 124: 931-7.
15. ADAMS J, POLSON DW, FRANKS S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 355-9.
16. GRULET H, DURLACH V, HECART AC, GROSS A, LEUTENEGGER M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Research and Clinical Practice 1993; 20: 201-7.
17. BERGMAN RN. Towards physiological understanding of glucose tolerance: minimal-model approach. Diabestes 1989; 8: 1512-27.
18. LASSARRE C, HARDOWIN S, DAFFOS F, SOVERTIER F, SRANKENHE F, BINOUX M. Serum insuline-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationship with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatric Research 1991; 29; 219-25.
19. CONTRERAS P, ZURA ML, AGUIRRE C, ET AL. La estimación clínica de la adiposidad no es un buen predictor de la sensibilidad tisular a la insulina medida con un análisis de modelo mínimo. Rev Méd Chile 1994; 122: 241-7.
20. GARVEY WT, OLEFSKY JM, GRIFFIN J, HAMMANN RF, KOLTERMAN OG. The effect of insulin treatment on insulin action and insulin secretion in type II diabetes mellitus. Diabetes 1985; 34: 222-34.
21. WILLIAMS R, BYRNE C, CLARK P, COX L, DAY NE, RAYMAN G, WANG T, HALES CN. Raised proinsulin concentration as early indicator Bcell dysfunction. BMJ 1991; 303: 95.
22. BOGARDUS C, LILLIOGA S, HOWARD B, REAVEN JM, MOLT D. Relationships between insulin secretion, insulin action and fasting plasma glucose concentrations in non diabetic and NIDDM sufojects. J Clin Invest 1984; 74: 1238-46.
23. GRULET H, HECART AC, DELEMERT B, GROSS A, SULMONT V, LEUTENEGGER M, CARON J. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol 1993; 38: 621-6.
24. BUYALOS R, GEFFNER M, WATANABE R, ET AL. The influence of luteininzing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertility and Sterility 1993; 60: 626-33.
25. PLYMATE SR, JONES LA, MATFJ LA, ET AL. Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin. J Clin Endocrinol Metab 1988; 52: 339-40.
26. PREZIOSI P, BARRETT-CONNOR E, PAPOZ L, ET AL. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study. J Clin Endocrinol Metab 1992; 76: 283-7.
27. PETRIS AN, STAGNER JI, PLYMATE SR, ET AL. Relationship of insulin secretory pulses to sex hormone-binding globulin levels in normal men. J Clin Endocrinol Metab 1993; 76: 279-82.
28. LINDSTEDT G, LUNDBERG PA, LAPIDUS L, ET AL. Low sex-hormone-binding globulin concentrations as independent risk factor for development of NIDDM. Diabetes 1991; 40: 123-8.
29. HOMBURG R, PARIENTE C, LUNENFELD B, JACOBS HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Human Reproduction 1992; 7: 1379-83.
30. BIRKELAND KI, HANSSEN KF, TORJESEN PA, ET AL. Level of sex hormone-binding is positively correlated with insulin sensitivity in men with type 2 diabetes (NIDDM). J Clin Endocrinol Metab 1993; 76: 275-8.
31. HALL K, BRISMAR K, GRISSON F, ET AL. IGF1-BP1. Production and control mechanism. Acta Endocrinol 1991; 124: 48-54.
32. NESTLER JE, MCCLANAHAN MA, CLORE JN, ET AL. Insulin inhibits 17,20-Lyase activity in man. J Clin Endocrinol Metab 1992; 74: 362-87.
33. ROBINSON S, KIDDY D, GELDING SV, WILLIS D, NITHTHYANANTHAN R, BUSH A, JOHNSTON D, FRANKS S. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-5.
34. FRANKS S, ROBINSON S, WILLIS DS. Nutrition, insulin and polycystic ovary syndrome. Reviews of Reproduction 1996; 1: 47-53.